SCHEMBL21167604

SCHEMBL21167604

Cn1cc(-c2cnc(N)c(NCc3ccn4nccc4n3)n2)cn1

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 5/20 0.62
MET P08581 4/20 0.55
MAPK1 P28482 3/20 0.38
MKNK1 Q9BUB5 3/20 0.38
FGFR1 P11362 1/20 0.38
FGFR2 P21802 1/20 0.38
FGFR3 P22607 1/20 0.38
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
MERTK Q12866 2/20 0.37
AXL P30530 1/20 0.37
LDHA P00338 1/20 0.37
LDHB P07195 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167444 0.87 CSF1R (0.46) CSF1RMETLDHALDHB
SCHEMBL24590999 0.84 MET (0.44) CSF1RMETLDHALDHB
SCHEMBL21167601 0.82 CSF1R (0.40) CSF1RMETMAPK1MKNK1LDHA
SCHEMBL21167565 0.82 CSF1R (0.62) CSF1RMETMAPK1MKNK1MERTK
SCHEMBL24591001 0.81 CSF1R (0.58) CSF1RMETMAPK1MKNK1FGFR1
SCHEMBL22475951 0.79 CSF1R (0.58) CSF1RMETMAPK1MKNK1FGFR1
SCHEMBL24591017 0.76 MET (0.43) CSF1RMETFGFR1FGFR2FGFR3
SCHEMBL21167443 0.76 MET (0.42) CSF1RMETMAPK1FGFR1FGFR2
SCHEMBL21167421 0.76 CSF1R (0.59) CSF1RMETMAPK1MKNK1LDHA
SCHEMBL21167364 0.74 CSF1R (0.60) CSF1RMETMAPK1MKNK1LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRIDINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR Hutchison Medipharma Limited (CN) 2021-03-24 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed